Upgrade to SI Premium - Free Trial

Xeris Pharmaceuticals Inc. (XERS)

6.50 +0.26 (4.17%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Form 4 Xeris Biopharma Holdings For: Jun 04 Filed by: Kong Garheng June 5, 2026 6:40 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Jun 03 Filed by: PERSKY MARLA June 5, 2026 6:29 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Jun 04 Filed by: BORMANN-KENNEDY BARBARA-JEAN ANNE June 5, 2026 6:18 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Jun 04 Filed by: HALKUFF DAWN June 5, 2026 6:18 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Jun 04 Filed by: JOHNSON JOHN June 5, 2026 6:18 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Jun 04 Filed by: Brady James Aloysius June 5, 2026 6:16 PM - SEC Filing Form 8-K Xeris Biopharma Holdings For: Jun 04 June 5, 2026 4:14 PM - SEC Filing Form 144 Xeris Biopharma Holdings Filed by: HALKUFF DAWN June 4, 2026 4:33 PM - SEC Filing Form 144 Xeris Biopharma Holdings Filed by: JOHNSON JOHN June 4, 2026 4:33 PM - SEC Filing Form 144 Xeris Biopharma Holdings Filed by: BORMANN-KENNEDY BARBARA-JEAN ANNE June 4, 2026 4:33 PM - SEC Filing Form 144 Xeris Biopharma Holdings Filed by: PERSKY MARLA June 3, 2026 4:26 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Jun 01 Filed by: Hecht Beth June 2, 2026 6:05 PM - SEC Filing Form 10-Q Xeris Biopharma Holdings For: Mar 31 May 7, 2026 4:11 PM - SEC Filing Form 8-K Xeris Biopharma Holdings For: May 07 May 7, 2026 7:16 AM - SEC Filing Xeris Pharmaceuticals Inc. (XERS) Tops Q1 EPS by 1c, provides guidance May 7, 2026 7:14 AM - StreetInsider Xeris Biopharma Reports First Quarter 2026 Financial Results May 7, 2026 7:00 AM - BizWire Form 4 Xeris Biopharma Holdings For: May 01 Filed by: Hecht Beth May 1, 2026 5:51 PM - SEC Filing Form DEFA14A Xeris Biopharma Holdings April 23, 2026 7:22 PM - SEC Filing Form ARS Xeris Biopharma Holdings For: Dec 31 April 23, 2026 7:22 PM - SEC Filing Form DEF 14A Xeris Biopharma Holdings For: Dec 31 April 23, 2026 7:22 PM - SEC Filing Xeris Biopharma to Report First Quarter 2026 Financial Results on May 7, 2026 April 23, 2026 7:30 AM - BizWire Form 8-K Xeris Biopharma Holdings For: Apr 20 April 21, 2026 4:27 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Apr 01 Filed by: Hecht Beth April 3, 2026 5:45 PM - SEC Filing Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) April 3, 2026 4:15 PM - BizWire Form 4 Xeris Biopharma Holdings For: Mar 30 Filed by: Brady James Aloysius April 1, 2026 5:54 PM - SEC Filing Form 144 Xeris Biopharma Holdings Filed by: Brady James Aloysius March 30, 2026 5:35 PM - SEC Filing Form SCHEDULE 13G/A Xeris Biopharma Holdings Filed by: VANGUARD GROUP INC March 27, 2026 2:13 PM - SEC Filing Barclays on Xeris Pharmaceuticals (XERS): 'LOE concerns overblown' March 19, 2026 12:46 PM - StreetInsider Form 4 Xeris Biopharma Holdings For: Mar 12 Filed by: McCulloch Kevin March 16, 2026 6:11 PM - SEC Filing Full Article List